fda compounded tirzepatide warning 2024 2025 ๐จ Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like semaglutide and tirzepatide, signaling a major shift in how these Important Notice: Tirzepatide Compounding Update
Description
Discuss realistic goals with your doctor to monitor the effectiveness of the therapy

Advertencia Legal: La Tirzepatida se suministra exclusivamente para fines de investigacin y desarrollo
Tirzepatide targets both GLP-1 and GIP receptors , providing appetite suppression through two pathways instead of one

One reviewer wrote that the doctor reviewed their information and approved them within the same day, and medication was delivered 48 hours later